Jeffrey Borghoff: Finding Joy and Purpose after an Early-onset Alzheimer’s Diagnosis

 

 

 

About this episode:

At 51, Jeffrey Borghoff was diagnosed with Alzheimer’s disease. What would devastate many people turned Borghoff into an advocate. The former software architect and developer is now a national spokesperson for the Alzheimer's Association and board member of the Greater New Jersey chapter.

In this podcast, he talks about how the diagnosis forced him to reprioritize his life. “I've been pretty successful at that. I've been leading a very purposeful, engaging, joyful life.” With his care partner—his wife, Kimberly—he travels around the country making the case for research funding—and for clinical trial participation. 

That’s critical because important Alzheimer’s trials focus on younger-onset AD patients. Unfortunately, many people who are beginning to show signs at a very young age want to deny they have the disease. They won’t go into trials or even get a diagnosis. His messages to them: This disease does not define who you are, and research is important.

About the Author

Steve Smith | President, Patient Advocacy, WCG

Steve Smith is a seasoned patient advocate with an extensive career in software, consulting, process transformation, health care systems and patient-focused drug development. He joined WCG as President Patient Advocacy in 2019 inspired by the incredible value to patients embedded in the wide range of WCG solutions that reduce the time and cost of clinical trials.

Visit Website More Content by Steve Smith | President, Patient Advocacy, WCG
Previous Post
LaTasha H. Lee, PhD, MPH: Advocating for health equity, advancing sickle cell disease research
LaTasha H. Lee, PhD, MPH: Advocating for health equity, advancing sickle cell disease research

Next Post
On the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials Series
On the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials Series